Literature DB >> 27621846

Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients.

Maosong Ye1, Xia Gu2, Yang Han3, Meiling Jin1, Tao Ren2.   

Abstract

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Patients with lung cancer are very frequently present with pulmonary infections, in particular with Gram-negative bacteria. Herein, we investigated the effect of the co-presence of Gram-negative bacteria on outgrowth and metastasis of lung cancer cells in clinical patients.
METHODS: Lung cancer cells were isolated from clinical surgical tissues. Heat-inactivated E. coli was used as Gram-negative bacteria. Tumor outgrowth and invasion in vitro was analyzed with MTT assay and Biocoat Matrigel Invasion Chamber. Tumor growth and metastasis in vivo was evaluated in BALB/c nude mice. Lipid synthesis was evidenced by expressions of FASN and ACC1, as well as BODIPY Fluorophores staining. Block lipid synthesis was performed with C75 as a FAS inhibitor and transfection with ACC1 siRNA. Knockdown of TLR4 and TLR9 signaling was achieved by transfection with specific shRNAs and administration of specific antagonists.
RESULTS: Gram-negative bacteria significantly promoted lung cancer development including growth and metastasis in dose dependent manner. Mechanistically, Gram-negative bacteria activate TLR4 and TLR9 signaling and enhance lipid synthesis in human lung cancer cells. Knockdown of TLR4 and/or TLR9 was able to block Gram-negative bacteria mediated lipid synthesis and lung cancer development. Interference with lipid synthesis efficiently abrogated Gram-negative-bacteria-induced lung cancer development. In lung cancer patients, higher expressions of innate immune receptors, TLR4 and TLR9, were observed in those with Gram-negative infections and associated with the aberrant lipid synthesis that was observed in vitro.
CONCLUSIONS: Pulmonary infections with Gram-negative bacteria lead to aberrant lipid synthesis through TLR4 and TLR9 signaling in lung cancer patients and result in rapid proliferation and metastasis of lung cancer cells. These findings reveal a new mechanism for pulmonary infection-trigged caner development and provide clues for exploring therapeutics for lung cancer patients.

Entities:  

Keywords:  Gram-negative bacteria; Lung cancer; TLR4; TLR9; lipid synthesis

Year:  2016        PMID: 27621846      PMCID: PMC4999763          DOI: 10.21037/jtd.2016.06.47

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  36 in total

1.  A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.

Authors:  Dan Qiao; Zhiyu Wang; Yaohong Lu; Xiaoting Wen; Hongtao Li; Hui Zhao
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 2.  ALK inhibitors in the treatment of advanced NSCLC.

Authors:  Cesare Gridelli; Solange Peters; Assunta Sgambato; Francesca Casaluce; Alex A Adjei; Fortunato Ciardiello
Journal:  Cancer Treat Rev       Date:  2013-08-07       Impact factor: 12.111

3.  Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo.

Authors:  Dan Li; Yingli Jin; Ying Sun; Jing Lei; Chaoying Liu
Journal:  Int J Oncol       Date:  2014-06-02       Impact factor: 5.650

Review 4.  Lung Cancer Statistics.

Authors:  Lindsey A Torre; Rebecca L Siegel; Ahmedin Jemal
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 5.  Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.

Authors:  Yi Zhang; Jin-Ming Yang
Journal:  Cancer Biol Ther       Date:  2012-11-28       Impact factor: 4.742

Review 6.  Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.

Authors:  Liem Minh Phan; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Cancer Biol Med       Date:  2014-03       Impact factor: 4.248

Review 7.  Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development.

Authors:  Franziska Baenke; Barrie Peck; Heike Miess; Almut Schulze
Journal:  Dis Model Mech       Date:  2013-11       Impact factor: 5.758

Review 8.  Metabolic alterations in cancer cells and therapeutic implications.

Authors:  Naima Hammoudi; Kausar Begam Riaz Ahmed; Celia Garcia-Prieto; Peng Huang
Journal:  Chin J Cancer       Date:  2011-08

Review 9.  Lipid metabolism, apoptosis and cancer therapy.

Authors:  Chunfa Huang; Carl Freter
Journal:  Int J Mol Sci       Date:  2015-01-02       Impact factor: 5.923

10.  EGFR-independent mechanisms of acquired resistance to AZD9291 in EGFR T790M-positive NSCLC patients.

Authors:  D Planchard; Y Loriot; F André; A Gobert; N Auger; L Lacroix; J C Soria
Journal:  Ann Oncol       Date:  2015-08-12       Impact factor: 32.976

View more
  7 in total

1.  Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.

Authors:  Mengyao Sun; Yang Bai; Song Zhao; Xiyu Liu; Yongsheng Gao; Lei Wang; Bin Liu; Dashi Ma; Chunye Ma
Journal:  Oncotarget       Date:  2018-01-04

2.  Indoor dust extracellular vesicles promote cancer lung metastasis by inducing tumour necrosis factor-α.

Authors:  Nhung Thi Hong Dinh; Jaewook Lee; Jaemin Lee; Sang Soo Kim; Gyeongyun Go; Seoyoon Bae; Ye In Jun; Yae Jin Yoon; Tae-Young Roh; Yong Song Gho
Journal:  J Extracell Vesicles       Date:  2020-05-19

3.  Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer.

Authors:  Jan A Stratmann; Raphael Lacko; Olivier Ballo; Shabnam Shaid; Wolfgang Gleiber; Maria J G T Vehreschild; Thomas Wichelhaus; Claudia Reinheimer; Stephan Göttig; Volkhard A J Kempf; Peter Kleine; Susanne Stera; Christian Brandts; Martin Sebastian; Sebastian Koschade
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

4.  Prognostic Significance of TLR2, SMAD3 and Localization-dependent SATB1 in Stage I and II Non-Small-Cell Lung Cancer Patients.

Authors:  Justyna Durślewicz; Anna Klimaszewska-Wiśniewska; Jakub Jóźwicki; Paulina Antosik; Marta Smolińska-Świtała; Maciej Gagat; Adam Kowalewski; Dariusz Grzanka
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

5.  Investigation and Functional Enrichment Analysis of the Human Host Interaction Network with Common Gram-Negative Respiratory Pathogens Predicts Possible Association with Lung Adenocarcinoma.

Authors:  Lydia-Eirini Giannakou; Athanasios-Stefanos Giannopoulos; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Erasmia Rouka; Sotirios G Zarogiannis
Journal:  Pathophysiology       Date:  2021-01-02

Review 6.  [Mechanism and Research Progress of Microbiome in the Development of Lung Cancer].

Authors:  Guohui Liu; Anxin Gu; Mingyan E
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-08-21

Review 7.  Infections in Hospitalized Cancer Patients.

Authors:  Amanda Delgado; Achuta Kumar Guddati
Journal:  World J Oncol       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.